Former IIFL Securities director challenges SEBI order for stock manipulation, denies allegations, and awaits SAT decision on ...

Glenmark Pharmaceuticals surged to a new all-time high in Thursday’s trade before closing up 5.5% at ₹1,919.60. The stock ...

This was originally published in the India File newsletter, which is issued every Tuesday. Sign up here to get the latest ...

Lawyers specialising in securities market matters say that since SEBI has passed an interim order, SAT could, without ...

The NSE report submitted in November 2024 concluded that Jane Street’s actions were “fraudulent and manipulative,” involving ...

Sebi justified the penalty, saying it must be imposed for non-compliances in order to ensure that the violations can be prevented in the future.

Moreover, the promoters plan to offer 94 lakh equity shares for sale, according to the Draft Red Herring Prospectus (DRHP).

Pharma stocks witnessed selling pressure on Thursday, a day after US President Donald Trump spoke about 200% tariffs on the ...

Proposal comes amid trading interest in index options remaining very large despite recent regulatory curbs to temper retail ...

Aggcon Equipments International plans to raise ₹332 crore through IPO for debt payment, equipment purchase, and corporate ...

Experts say the new framework will boost co-investments, ease regulatory friction, and help bridge India’s mid-market credit ...

Viceroy Research said that submitting the report to the regulator will provide a public forum where accountability can be ...